VALA SCIENCES INC.
- SAN DIEGO, CA 92121-4701
- valasciences.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $300K
- Awards on record
- 1
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 38 days
VALA SCIENCES INC.’s registration expires on Dec 22, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About VALA SCIENCES INC.
- Headquarters
- SAN DIEGO, CA 92121-4701
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEICZZJVX2BKJF3
- CAGE47YK2
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $300K
- Awards on record
- 1
- Top funding agencies
- National Institutes of Health
Awards
75N95024C00035
Completed: Period of performance ended Sep 26, 2025SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH) VALA SCIENCES…
Department of Health and Human Services · National Institutes of Health
- Obligated
- $300K
- Period of performance
- Sep 27, 2024 – Sep 26, 2025
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N95024C00035 SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH) VALA SCIENCES… | Department of Health and Human Services · National Institutes of Health | 541715 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $300K | Sep 27, 2024 – Sep 26, 2025 | Completed: Period of performance ended Sep 26, 2025 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 39 awards
- Total awarded
- $28,112,114
- By phase
- SBIR Phase I: 17
- SBIR Phase II: 9
- STTR Phase I: 8
- STTR Phase II: 5
- By agency
- Department of Health and Human Services: 39
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 3
- 2023: 3
- 2021: 2
- 2019: 1
- 2018: 4
- 2016: 1
- 2015: 1
- 2014: 2
- 2013: 4
- 2012: 1
- 2011: 5
- 2010: 2
- 2008: 4
- 2007: 1
- 2006: 5
Awards (most recent first)
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $2,232,437
Sep 1, 2024 – Aug 31, 2026
Solicitation PA22-176 (2022) · Topic 105
An assay suite featuring hiPSC-derived neurons and support cells, to test toxicants and industrial chemicals for developmental neurotoxic effects
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,972,828
Jun 19, 2024 – May 31, 2026
Solicitation ES23-008 (2023) · Topic R
SBIR PHASE 1 (NIH/NIMH TOPIC 002 - DEVELOPMENT OF NOVEL IN-VITRO AND IN-VIVO MODELS TO SUPPORT NEUROHIV RESEARCH)
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $300,000
Solicitation PHS-2024-1 (2024) · Topic 2
The Pain in a Dish Assay (PIDA): a high throughput system featuring human stem cell-derived nociceptors and dorsal horn neurons to test compounds for analgesic activity
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $350,064
Sep 1, 2023 – Aug 31, 2024
Solicitation NS23-006 (2023) · Topic 100
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo and HIV ARTs)
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $565,745
Sep 1, 2023 – Aug 31, 2024
Solicitation PA22-176 (2022) · Topic 105
Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2023 · $2,464,273
Aug 3, 2023 – Jul 31, 2025
Solicitation PA20-265 (2020) · Topic NHLBI · Research partner: STANFORD UNIVERSITY
Combined Cardiomyopathy, e.g., of Cancer Chemotherapeutics, and Proarrhythmia for Cardiotoxicity Clinical Trials-in-a-Dish (CTiD) with iPSC-Derived Cardiomyocytes
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $299,871
Jun 1, 2021 – May 31, 2022
Solicitation PA20-265 (2020) · Topic NHLBI · Research partner: STANFORD UNIVERSITY
The hCNS-HIV/ARV assay system, a platform utilizing human iPSC-neurons/-microglia/-astrocytes to test HIV/AIDS therapeutics for neurotoxicity related to HIV-associated cognitive disroder (HAND)
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2021 · $1,916,189
May 1, 2021 – Apr 30, 2023
Solicitation PA20-260 (2020) · Topic 105
TOPIC 382 - THE MICROSCOPIC IMAGING OF EPIGENETIC LANDSCAPE BREAST TUMOR DIFFERENTIATION (MIEL-BTD) ASSAY: A HIGH THROUGHPUT SCREEN TO IDENTIFY NOVEL THERAPEUTICS FOR BREAST CANCER.
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $299,923
Solicitation year 2018 · Topic NCI
The Alzheimer's Therapeutics Screening Assay: a high-throughput drug-discovery platform utilizing neurons and microglia derived from human induced pluripotent stem cells and Kinetic Image Cytometry
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $301,078
Sep 30, 2018 – Aug 31, 2019
Solicitation PAS18-187 (2018) · Topic NIA
The Stem Cell-Derived Muscle Function Assay: A High Throughput Screening Platform Utilizing Kinetic Image Cytometry to Discover Therapeutics for Duchenne Muscular Dystrophy
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $225,000
Sep 19, 2018 – Aug 31, 2019
Solicitation AR18-005 (2017) · Topic NIAMS
The Microscopic Imaging of Epigenetic Landscape- NeuroDevelopment (MIEL-ND) assay: a high throughput platform to screen compounds for neurodevelopmental effects
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $300,000
Sep 10, 2018 – Sep 9, 2019
Solicitation PA17-148 (2017) · Topic 101 · Research partner: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY
Assay of chemicals for Parkinson's toxicity in human iPSC-derived neurons
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $2,008,017
Jun 1, 2018 – May 31, 2020
Solicitation ES17-007 (2017) · Topic NIEHS
Stem cell toxicology assays for cardiac differentiation
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,499,999
Mar 1, 2016 – Aug 31, 2018
Solicitation ES15-006 (2015) · Topic NIEHS
Assay of chemicals for Parkinson’s toxicity in human iPSC-derived neurons
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $224,926
Sep 1, 2015 – Aug 31, 2016
Solicitation ES15-006 (2015) · Topic 113
IGF::OT::IGF SBIR TOPIC 328, IN VITRO ASSAY OF THE INITIATION OF BREAST CANCER METASTASIS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $223,048
Solicitation year 2014 · Topic NCI · Research partner: Stub
IGF::OT::IGF
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,074,832
Solicitation year 2014 · Topic NIDA · Research partner: Stub
Kinetic image cytometry assays for neuronal activity/toxicity
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $300,000
Solicitation PA12-089 (2013) · Topic NCI · Research partner: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Association Analysis Software for Mining Clinical Next-Gen Sequencing Data
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $224,549
Solicitation ES13-003 (2013) · Topic NIEHS · Research partner: Stub
Optogenetic Multiparametric Assay for HT Cardiotoxicity Testing
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2013 · $1,231,507
Solicitation PA11-097 (2013) · Topic NHLBI · Research partner: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
FY-2013 Contract HHSN271201300010C, Topic 004. A High Throughput Assay for Neur
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $149,837
Solicitation year 2013 · Topic NIDA · Research partner: Stub
Optogenetic Multiparametric Assay for HT Cardiotoxicity Testing
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $221,765
Solicitation PA11-097 (2012) · Topic NHLBI · Research partner: INDIANA STATE UNIVERSITY
Automated Analysis of Skeletal Muscle Fiber Cross-sectional Area and Metabolic Ty
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2011 · $1,188,087
Solicitation PA10-051 (2011) · Topic NIAMS · Research partner: INDIANA UNIVERSITY
Automated quantification of lipid droplets in fatty liver tissue sections
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2011 · $1,458,397
Solicitation PA10-051 (2011) · Topic NIDDK · Research partner: UNIVERSITY OF CALIFORNIA
TAS::75 0849::TAS RandD-OTHER SCIENCES-B RES
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2011 · $1,730,100
Solicitation year 2011 · Topic NCI · Research partner: Stub
Showing the 25 most recent of 39 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
- 334516Analytical Laboratory Instrument Manufacturing
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with VALA SCIENCES INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.